Search
Making the European Region Safer: developments in alcohol control policies, 2010–2019 (2021)
This report presents the current status of alcohol consumption, alcohol-attributable harms and the implementation of alcohol control policies in the WHO European Region, using available data from 2010, 2016 and 2019.
A detailed overview...
WHO Quitting Toolkit
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care
Making the European Region Safer: Developments in Alcohol Control Policies, 2010–2019
This report presents the current status of alcohol consumption, alcohol-attributable harms and the implementation of alcohol control policies in the WHO European Region, using available data from 2010, 2016 and 2019.
A detailed overview...
WHO Guideline: Recommendations on Digital Interventions for Health System Strengthening
The key aim of this guideline is to present recommendations based on a critical evaluation of the evidence on emerging digital health interventions that are contributing to health system improvements, based on an assessment of the benefits...
How Can Telehealth Help in the Provision of Integrated Care?
The World Health Organisation defines telehealth as:
The use of telecommunications and virtual technology to deliver health care outside of traditional health-care facilities.
Well-designed telehealth schemes can improve health care...
Alcohol Use, Alcohol Dependence and Mental Health Conditions
Several key risk factors for noncommunicable diseases (NCDs) have been identified, including the harmful use of alcohol.
Half the world’s population drinks alcohol, and harmful alcohol use is the third leading cause of ill health and...
WHO Global Report on Trends in Prevalence of Tobacco Use 2000-2025
Tobacco is the only legal drug that kills many of its users when used exactly as intended by manufacturers. WHO has estimated that tobacco use (smoking and smokeless) is currently responsible for the death of about six million people across...
The International Guidelines on Human Rights and Drug Policy
Intervention guide mhGAP for mental, neurological disorders and substance use in the level of non-specialized health care. Version 2.0
Mental, neurological and substance (MNS) disorders are very common and represent a large burden of disease and disability around the world. There remains a wide gap between the capacity of health systems and resources, between what is...
mhGAP Intervention Guide - Version 2.0 for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings
Overview
This is the second version (2016) of the mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist health settings. It is for use by doctors, nurses, other health workers as...
Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy
These guidelines contain recommendations on the identification and management of substance use and substance use disorders for health care services which assist women who are pregnant, or have recently had a child, and who use alcohol or...
Growing up unequal: gender and socioeconomic differences in young people's health and well-being. Health Behaviour in School-aged Children (HBSC) study
This book is the latest addition to a series of reports on young people's health from the Health Behaviour in School-aged Children (HBSC) study: a WHO collaborative cross-national study that has provided information about the health, well...
From Coercion to Cohesion: Treating Drug Dependence through Health Care, Not Punishment
The aim of this draft discussion paper, “From coercion to cohesion: Treating drug dependence through health care, not punishment”, is to promote a health-oriented approach to drug dependence. The International Drug Control Conventions give...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member